Mayer Brown

Dominique Ehinger

Deals
1
Latest
May 2026

Firm

Often works with

Deals

US deals dated after 30 September 2026 are still being collected.

Columns
Deals Dominique Ehinger was named on, most recent first
May 2026 Exclusive development and commercialisation rights to Idefirix in Europe and MENA Hansa Biopharma ABSERB PharmaceuticalsAsset saleLegal adviser to SERB Pharmaceuticals (acquirer)Pending133.6Pharma+1SERB Pharmaceuticals acquisition of Exclusive development and commercialisation rights to Idefirix in Europe and MENA

Deals where Dominique Ehinger is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.